Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29 SEK | +6.15% | +3.06% | +10.69% |
04-18 | Transcript : Hansa Biopharma AB, Q1 2024 Earnings Call, Apr 18, 2024 | |
04-18 | Hansa Biopharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.69% | 137M | |
+2.62% | 42.75B | |
+47.70% | 41.61B | |
+12.08% | 41.34B | |
-8.83% | 26.59B | |
+7.98% | 25.49B | |
-22.45% | 18.12B | |
+31.23% | 12.24B | |
-1.37% | 11.76B | |
+8.48% | 11B |
- Stock Market
- Equities
- HNSA Stock
- News Hansa Biopharma AB
- Hansa Biopharma Starts Phase 3 For Autoimmune Drug Imlifidase; Shares Up 7%